Animal studies using apolipoprotein E-deficient mice (ApoE(−/−)), an atherosclerosis mouse model, were used to determine whether the modulation of IAV-induced MCP-1 and IP-10 by metformin alleviates the underlying disease associated with influenza virus infection. Here, CXCL10 is linked to atherosclerosis.